Pharming (PHAR) Retained Earnings (2019 - 2025)

Pharming's Retained Earnings history spans 7 years, with the latest figure at $28.8 million for Q4 2025.

  • Quarterly results put Retained Earnings at $28.8 million for Q4 2025, up 110.46% from a year ago — trailing twelve months through Dec 2025 was $28.8 million (up 110.46% YoY), and the annual figure for FY2025 was $28.8 million, up 110.46%.
  • Retained Earnings for Q4 2025 was $28.8 million at Pharming, up from -$275.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $28.8 million in Q4 2025 to a low of -$275.5 million in Q4 2024.
  • The 5-year median for Retained Earnings is -$2.1 million (2023), against an average of -$50.8 million.
  • The sharpest move saw Retained Earnings crashed 13292.76% in 2024, then skyrocketed 110.46% in 2025.
  • Year by year, Retained Earnings stood at $3.4 million in 2021, then crashed by 356.97% to -$8.7 million in 2022, then surged by 76.46% to -$2.1 million in 2023, then crashed by 13292.76% to -$275.5 million in 2024, then surged by 110.46% to $28.8 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $28.8 million, -$275.5 million, and -$2.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.